Kameron Klosterman, MD
Family Medicine · Pacolet, SCNPI 1609984715
Payments from drug & device makers
Across 184 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$534
- Astellas Pharma US Inc$414
- Dexcom, Inc.$302
- Lilly USA, LLC$250
- Amarin Pharma, Inc.$222
- Amgen$221
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,06595%
- Education$1475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $534 |
| Astellas Pharma US Inc | 14 | $414 |
| Dexcom, Inc. | 15 | $302 |
| Lilly USA, LLC | 15 | $250 |
| Amarin Pharma, Inc. | 14 | $222 |
| Amgen | 15 | $221 |
| Novo Nordisk | 14 | $197 |
| Johnson & Johnson | 10 | $159 |
| Pfizer | 7 | $123 |
| Kowa Pharmaceuticals America, Inc. | 5 | $94 |
| Exact Sciences | 5 | $89 |
| AstraZeneca | 6 | $86 |
| Merck | 5 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| GSK | 4 | $65 |
| Abbott | 3 | $55 |
| Novartis | 2 | $38 |
| Inari Medical, Inc. | 1 | $33 |
| Stryker | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Edwards Lifesciences | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$3,212 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $79,826 |
| EliquisApixaban | 67 | $70,937 |
| XareltoRivaroxaban | 18 | $27,584 |
| MounjaroTirzepatide | 17 | $20,530 |
| JanuviaSitagliptin Phosphate | 12 | $19,258 |
| JardianceEmpagliflozin | 11 | $15,987 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $12,013 |
| Repatha SureclickEvolocumab | 11 | $10,540 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 12 | $9,854 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $5,430 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,958 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 101 | $4,745 |
| Atorvastatin Calcium | 344 | $3,231 |
| Esomeprazole Magnesium | 29 | $2,935 |
| Rosuvastatin Calcium | 109 | $2,336 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $197 | $79,82655 claims |
| PfizerEliquis | $123 | $70,93767 claims |
| Johnson & JohnsonXarelto | $159 | $27,58418 claims |
| Lilly USA, LLCMounjaro | $250 | $20,53017 claims |
| MerckJanuvia | $84 | $19,25812 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $65 | $16,97130 claims |
| Boehringer IngelheimJardiance | $21 | $15,98711 claims |
| AbbVieSynthroid | $534 | $83713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Pacolet
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.